… ) vein, … cerebral magnetic resonance (MR) perfusion studies. CCSVI is strongly associated
with multiple sclerosis (MS). This study evaluated the safety of CCSVI endovascular treatment …

… ) vein, … cerebral magnetic resonance (MR) perfusion studies. CCSVI is strongly associated
with multiple sclerosis (MS). This study evaluated the safety of CCSVI endovascular treatment …

… endovascular treatment for chronic cerebrospinal venous insufficiency in a group of clinically
defined multiple sclerosis patients. There were assessed clinical results of the treatment of …

… ) vein, … cerebral magnetic resonance (MR) perfusion studies. CCSVI is strongly associated
with multiple sclerosis (MS). This study evaluated the safety of CCSVI endovascular treatment …

… studies evaluating clinical efficacy of venous angioplasty in selected MS patients. Importantly,
all aforementioned trials and also the open-label surveys have demonstrated that venous …

… 30 days of endovascular treatment of CCSVI. The study population comprised 240 patients;
257 procedures were performed over 8 months. The indication for treatment in all patients …

… angioplasty (PTA) of the extracranial veins significantly improved MS clinical and radiological
outcome measures in a prospective open-label study [Citation10]. The controversial …

… treatment of choice for lesions producing venous disease. Nowadays, a few reports have been
reported on endovascular treatment … aim of the present study is to retrospectively evaluate …

… The aim of this study was to evaluate the safety of endovascular treatments in the territory
of … veins (IJVs) and the azygous vein (AV) for the so-called chronic cerebrospinal venous …

… OBJECTIVE: In this study, the mid-term results (6 month follow-up) of the endo… (2009) A
prospective open-label study of endovascular treatment of chronic cerebrospinal venous insuf…